THUNDER BAY, Ontario--(BUSINESS WIRE)--IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, ...

SCC in situ has several clinical presentation forms including Bowen's disease and erythroplasia of Queyrat. Bowen's disease may appear in any part of the skin, nail, or mucous membranes. It appears ...

Real life experience with check point and kinase inhibitors in Swiss advanced melanoma patients. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a ...

Please provide your email address to receive an email when new articles are posted on . There were no significant differences in outcomes for patients with melanoma in situ who were treated with Mohs ...

Please provide your email address to receive an email when new articles are posted on . In light of recent appropriate-use criteria, researchers have found Mohs micrographic surgery was an appropriate ...

Every time Tom publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...

Maternal mirror syndrome can lead to serious complications for mother and fetus. Here are causes, symptoms, management, treatment of Ballantyne Syndrome or MMS Maternal mirror syndrome (MMS) is a rare ...

THUNDER BAY, Ontario — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, an anti-CoV-2 ...